1. A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer. (26th December 2019) Authors: Yarchoan, Mark; Huang, Chiung‐Yu; Zhu, Qingfeng; Ferguson, Anna K.; Durham, Jennifer N.; Anders, Robert A.; Thompson, Elizabeth D.; Rozich, Noah S.; Thomas, Dwayne L.; Nauroth, Julie M.; Rodriguez, Christina; Osipov, Arsen; De Jesus‐Acosta, Ana; Le, Dung T.; Murphy, Adrian G.; Laheru, Daniel; Don... Journal: Cancer medicine Issue: Volume 9:Number 4(2020) Page Start: 1485 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CD137 agonist-based combination immunotherapy enhances activated, effector memory T cells and prolongs survival in pancreatic adenocarcinoma. (28th February 2021) Authors: Muth, Stephen T.; Saung, May Tun; Blair, Alex B.; Henderson, MacKenzie G.; Thomas, Dwayne L.; Zheng, Lei Journal: Cancer letters Issue: Volume 499(2021) Page Start: 99 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer. Issue 1 (13th November 2018) Authors: Saung, May Tun; Muth, Stephen; Ding, Ding; Thomas, Dwayne L.; Blair, Alex B.; Tsujikawa, Takahiro; Coussens, Lisa; Jaffee, Elizabeth M.; Zheng, Lei Journal: Journal for immunotherapy of cancer Issue: Volume 6:Issue 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗